HCW Biologics Inc.

HCWBNasdaqCIK 1828673HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 151 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

HCW Biologics Inc., Reports and events
Filed	Form	What it is	Accession number
2026-10-0220:30 ET	S-1	Registration statement	0001493152-26-045532
2026-10-0114:00 ET	DEF 14A	Proxy statementPeriod 2026-10-01	0001493152-26-045289
2026-09-2412:30 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001493152-26-044078
2026-09-1022:02 ET	8-K	7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001493152-26-042009
2026-09-0813:00 ET	8-K	1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-26-041716
2026-08-2820:42 ET	S-1/A	Registration statement, amended	0001493152-26-040618
2026-08-2018:58 ET	S-1	Registration statement	0001493152-26-039452
2026-08-1419:30 ET	10-Q	Quarterly reportPeriod 2026-06-30	0001493152-26-038262
2026-08-1419:20 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-26-038258
2026-08-1419:10 ET	10-Q/A	Quarterly report, amendedPeriod 2026-03-31	0001493152-26-038246
2026-08-1419:00 ET	8-K	4.02 Non-reliance on financial statements	0001493152-26-038240
2026-07-2921:12 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001493152-26-035233
2026-07-0112:30 ET	8-K	8.01 Other events	0001493152-26-031441
2026-06-3012:30 ET	8-K	3.01 Delisting notice; 9.01 Financial statements and exhibits	0001493152-26-031204
2026-06-2613:00 ET	8-K	3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-26-030236
2026-06-1817:05 ET	S-1/A	Registration statement, amended	0001493152-26-029235
2026-06-1611:15 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001493152-26-028807
2026-06-1520:30 ET	8-K	5.07 Shareholder vote results	0001493152-26-028699
2026-06-0814:10 ET	S-1	Registration statement	0001493152-26-027656
2026-06-0111:30 ET	8-K	3.01 Delisting notice	0001493152-26-026529
2026-05-2712:00 ET	8-K	1.02 Termination of a material agreement; 9.01 Financial statements and exhibits	0001493152-26-025336
2026-05-2120:59 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001493152-26-024850
2026-05-1420:31 ET	10-Q	Quarterly reportPeriod 2026-03-31	0001493152-26-023131
2026-05-1420:31 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001493152-26-023122
2026-04-3020:30 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001493152-26-020587
2026-04-3001:24 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001493152-26-019699
2026-04-2815:24 ET	DEF 14A	Proxy statementPeriod 2026-04-28	0001493152-26-019409
2026-04-2421:30 ET	S-1/A	Registration statement, amended	0001493152-26-018992
2026-04-2321:12 ET	S-1	Registration statement	0001493152-26-018758
2026-04-1620:30 ET	8-K	5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits	0001493152-26-017099
2026-03-3121:12 ET	10-K	Annual reportPeriod 2025-12-31	0001193125-26-134934
2026-03-3121:12 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-26-134936
2026-03-1712:00 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001193125-26-109407
2026-03-1320:15 ET	DEF 14A	Proxy statementPeriod 2026-03-13	0001493152-26-010060
2026-03-0213:08 ET	8-K	3.01 Delisting notice; 9.01 Financial statements and exhibits	0001193125-26-084291
2026-02-1921:43 ET	8-K	1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 8.01 Other events	0001193125-26-059578
2026-02-1714:09 ET	S-1/A	Registration statement, amended	0001193125-26-053303
2026-02-1321:04 ET	S-1/A	Registration statement, amended	0001193125-26-051317
2026-02-1313:38 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001193125-26-049953
2026-02-1122:27 ET	S-1	Registration statement	0001193125-26-046873
2026-01-0921:49 ET	S-1	Registration statement	0001193125-26-009044
2025-12-3117:36 ET	8-K	8.01 Other events	0001193125-25-338026
2025-11-2021:30 ET	8-K	1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001193125-25-289873
2025-11-1901:25 ET	8-K	1.01 Entry into a material agreement	0001193125-25-286642
2025-11-1812:30 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001193125-25-285325
2025-11-1421:52 ET	10-Q	Quarterly reportPeriod 2025-09-30	0001193125-25-283238
2025-11-1421:50 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-25-283230
2025-10-1613:00 ET	8-K	3.01 Delisting notice	0001193125-25-240890
2025-09-0520:39 ET	8-K	1.01 Entry into a material agreement	0000950170-25-113265
2025-08-1921:00 ET	8-K	3.01 Delisting notice	0000950170-25-110174

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:15 ET. Listed shows no prices and gives no investment advice.